Publicaciones (91) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

  2. A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 5

  3. A New Family of Subnanomolar inhibitors of Soluble Epoxide Hydrolase

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36

  4. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

  5. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer

    Nature Communications, Vol. 13, Núm. 1

  6. Addressing the at-home care needs of patients with multidrug-resistant bacteria: What should we do?

    European Journal of Hospital Pharmacy

  7. Adherencia terapéutica de ácido obeticólico: experiencia real utilizando sistemas de monitorización de medicación electrónicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 260-264

  8. An Experience of Using a Canvas-Based Template for Blended-Learning in a Master in Drug Discovery

    International Journal of Emerging Technologies in Learning, Vol. 17, Núm. 6, pp. 257-267

  9. Analysis of medication persistence and reasons for discontinuation of treatment with teriflunomide and dimethyl fumarate in a hospital series of patients with multiple sclerosis

    Neurology Perspectives, Vol. 2, Núm. 3, pp. 168-170

  10. Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 6, pp. 941-953

  11. Aumento de niveles séricos de Ciclofilina C en el seguimiento de la enfermedad arterial coronaria: un biomarcador y posible predictor clínico

    Archivos de cardiologia de Mexico, Vol. 92, Núm. 2, pp. 189-195

  12. Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer (Nature Communications, (2022), 13, 1, (4829), 10.1038/s41467-022-31859-3)

    Nature Communications

  13. Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat

    ACS Nano, Vol. 16, Núm. 9, pp. 14210-14229

  14. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  15. Capecitabine: Guaranteed access in adjuvant treatment of breast cancer

    European Journal of Hospital Pharmacy

  16. Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic

    DMM Disease Models and Mechanisms, Vol. 15, Núm. 12

  17. Cuadro de mando de Telefarmacia: Indicadores de actividad y calidad de la atención farmacéutica de un servicio de farmacia de hospital

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 7, pp. 92-105

  18. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  19. Defining a new term: Defensive hospital pharmacy practices

    European Journal of Hospital Pharmacy

  20. Delayed Pressure Urticaria: Clinical and Diagnostic Features and Response to Omalizumab

    International Archives of Allergy and Immunology, Vol. 183, Núm. 10, pp. 1089-1094